Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research ...

UC San Diego’s latest study reveals MICAL2 as a critical factor in pancreatic cancer progression, offering new avenues for treatment through targeted therapies that could inhibit this enzyme and slow ...

The paper investigates a potential cause of a type of severe epilepsy that develops in early life because of a defect in a gene called KCNQ2. The significance is fundamental because it substantially ...

What is a 5-year relative survival rate? Where do these numbers come from? 5-year relative survival rates for pancreatic cancer Understanding the numbers Keep in mind that survival rates are estimates ...

14 Southern California Research Center for ALPD and Cirrhosis, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA The field of pancreatic stellate cell (PSC ...

Background: In recent years, the incidence of patients with colorectal neuroendocrine neoplasms (CRNENs) has been continuously increasing. When diagnosed, most patients have distant metastases. Liver ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.